ArticleCancer management and research2022

Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer.

Nicolas Pennarun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.